Most Read Articles
15 Oct 2017
Physiotherapy and behaviour therapy appear to be effective interventions in females with overactive bladder syndrome, with those who have had no previous exposure to the treatments benefitting from post-therapy effects, a recent study has shown.
22 May 2015
A highly selective M3 antagonist developed for treating overactive bladder (OAB).

Solifenacin succinate improves urinary incontinence in Parkinson’s disease patients with overactive bladder

01 May 2015
Solifenacin succinate improves urinary incontinence in Parkinson’s disease patients with overactive bladder (OAB), according to a double-blind, randomised, placebo-controlled, 3-site study with an open-label extension phase. Improvement in the number of micturitions per 24 hours (p = 0.03) and decrease in the number of urinary incontinence episodes per 24 hours (p=0.01) were observed with solifenacin treatment.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
15 Oct 2017
Physiotherapy and behaviour therapy appear to be effective interventions in females with overactive bladder syndrome, with those who have had no previous exposure to the treatments benefitting from post-therapy effects, a recent study has shown.
22 May 2015
A highly selective M3 antagonist developed for treating overactive bladder (OAB).